| Code | 92721 | ||||||||||
| MA number | 29/0260/05-S | ||||||||||
| Product Form: | sup 5x125 mg | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Mutual recognition procedure | ||||||||||
| Therapeutic Class: | 29 - ANTIRHEUMATICA, ANTIPHLOGISTICA, ANTIURATICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Container: | blister Al/Al | ||||||||||
| Route of admin.: | Rectal use |
| Prescription Status: | Medicinal product not subject to medical prescription. |
| Legal basis: | Article 10a well-established use application |
| MA issued: | 06.09.2005 |
| Pediatric indication: | Yes |
| Pediatric posology: | Yes |
| Pediatric warnings: | Yes |
| SPC: |
SPC_NUROFEN pre deti čapíky 125 mg_09.2023.pdf
|
| PIL: |
PIL_NUROFEN pre deti čapíky 125 mg_09.2023.pdf
|
| Safety feature | No |
| Data update: | 25.06.2019 |
